BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$84.86−0.40 (-0.47%)
Close on Nov 17, 2026Market cap $21.32BP/E –Yield –
BioNTech operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was €456.00M, up 119.5% from the year before. The highest annual figure on record is €13.58B in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €456.00M | +119.5% |
| FY2024 | Dec 31, 2024 | €207.70M | -96.1% |
| FY2023 | Dec 31, 2023 | €5.37B | -60.4% |
| FY2022 | Dec 31, 2022 | €13.58B | +1426.1% |
| FY2021 | Dec 31, 2021 | €889.70M | – |
| FY2020 | Dec 31, 2020 | -€13.50M | – |
| FY2019 | Dec 31, 2019 | -€198.50M | – |
| FY2018 | Dec 31, 2018 | -€58.88M | – |
| FY2017 | Dec 31, 2017 | -€52.56M | – |
See a number that looks wrong?